Author: Zhang X. Jin L. Takenaka I.
Publisher: Elsevier
ISSN: 0090-4295
Source: Urology, Vol.52, Iss.5, 1998-11, pp. : 925-931
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Nakopoulou L. Constantinides C. Papandropoulos J. Theodoropoulos G. Tzonou A. Giannopoulos A. Zervas A. Dimopoulos C.
Urology, Vol. 46, Iss. 3, 1995-09 ,pp. :
p53 and HER-2 alterations in renal cell carcinoma
By Zhang X.-H. Takenaka I. Sato C. Sakamoto H.
Urology, Vol. 50, Iss. 4, 1997-10 ,pp. :
p53 in bladder cancer: mechanism of action, prognostic value, and target for therapy
By Slaton J.W. Benedict W.F. Dinney C.P.N.
Urology, Vol. 57, Iss. 5, 2001-05 ,pp. :
Quinolone antibiotics: a potential adjunct to intravesical chemotherapy for bladder cancer
By Kamat A.M. DeHaven J.I. Lamm D.L.
Urology, Vol. 54, Iss. 1, 1999-07 ,pp. :